Abstracts - faqs.org

Abstracts

Business, regional

Search abstracts:
Abstracts » Business, regional

Biotech moves in at Navy Base

Article Abstract:

AppTec Laboratory Services, in its 75,000-square-foot facility, has helped its 600 clients take new medicines from the earliest laboratory testing through manufacturing for the required clinical trials and finally to market. These services have entered the pharmaceutical manufacturing business in a new building at the old Philadelphia Navy Base and it is hoped that the plant would launch a biotechnology complex in South Philadelphia.

Author: Holcomb. Henry J.
Publisher: Philadelphia Newspapers, Inc.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2004
Services information, Services, Clinical trials, AppTec

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


News that maker hid Vioxx data sinks stock 10%

Article Abstract:

Shares of Merck & Co. Inc, one of the world's largest drugmaker has declined more than 10% on November 1, 2004 after its withdrawal of its arthritis drug, Vioxx due to lawsuits filed against the company over Vioxx. Vioxx was consumed by about 20 million Americans and had produced 11 percent of Merck's total revenue.

Publisher: Philadelphia Newspapers, Inc.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2004
Product standards, safety, & recalls, Securities issued, listed, Product defects and recalls, Securities, Company securities, Vioxx (Medication), Merck & Company Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Non-approved prescriptions' woes in focus

Article Abstract:

Pfizer Inc., marketed its epilepsy drug Neurontin without any approval from the Food and Drug Administration (FDA). Pfizer agreed to pay $430 million in criminal and civil penalties to federal and state agencies because of unapproved Neurontin by FDA.

Author: Adams, Chris, Young, Alison
Publisher: Philadelphia Newspapers, Inc.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2004
Discipline, Pfizer Inc., PFE, United States. Food and Drug Administration

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Pharmaceutical industry
Similar abstracts:
  • Abstracts: Political jambalaya. Neighborly relations
  • Abstracts: Beaver wants say in power plant swap. Merger decision due. PUC will reconsider power deal
  • Abstracts: Broadest decline for U.S. stocks in 2 months. Economy's gains slowed as trade deficit widened. Retail sales benefit stocks: The markets rebounded moderately following a stronger-than-expected Commerce Dept. report
  • Abstracts: Lower prices increases ease inflation worries. Economy slower than first thought. Board rules against federal loan guarantee for United
  • Abstracts: Is management locked out at the Labor Department? Business and labor square off over prevailing wage. Sheets Construction moves up to the penthouse suite
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.